Comorbidity measures for use with administrative data.
The DOI matches its Crossref record; 30 of the 33 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: This study attempts to develop a comprehensive set of comorbidity measures for use with large administrative inpatient datasets. METHODS: The study involved clinical and empirical review of comorbidity measures, development of a framework that attempts to segregate comorbidities from other aspects of the patient's condition, development of a comorbidity algorithm, and testing on heterogeneous and homogeneous patient groups. Data were drawn from all adult, nonmaternal inpatients from 438 acute care hospitals in California in 1992 (n = 1,779,167). Outcome measures were those commonly available in administrative data: length of stay, hospital charges, and in-hospital death. RESULTS: A comprehensive set of 30 comorbidity measures was developed. The comorbidities were associated with substantial increases in length of stay, hospital charges, and mortality both for heterogeneous and homogeneous disease groups. Several comorbidities are described that are important predictors of outcomes, yet commonly are not measured. These include mental disorders, drug and alcohol abuse, obesity, coagulopathy, weight loss, and fluid and electrolyte disorders. CONCLUSIONS: The comorbidities had independent effects on outcomes and probably should not be simplified as an index because they affect outcomes differently among different patient groups. The present method addresses some of the limitations of previous measures. It is based on a comprehensive approach to identifying comorbidities and separates them from the primary reason for hospitalization, resulting in an expanded set of comorbidities that easily is applied without further refinement to administrative data for a wide range of diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“prescription of these newer glucose-lowering medications is low in both type 2 diabetes and patients with CKD.17,18”
From Disparities in SGLT2 Inhibitor or Glucagon-Like Peptide 1 Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United States (2023) · cites this paper as [18]
In the citing paper
“The Elixhauser Comorbidity Index includes a comprehensive set of 30 comorbid condition measures (covering acute and chronic conditions) and has been used to assess prevalent comorbid conditions in health research for examining medication use.18,22”
From Disparities in SGLT2 Inhibitor or Glucagon-Like Peptide 1 Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United States (2023) · cites this paper as [18]
In the citing paper
“A recent retrospective analysis using 2015-2019 data from the Optum Clinformatics Data Mart suggested that the prescription of SGLT2i was low in commercially insured patients with type 2 diabetes and showed racial/ethnic, sex, and socioeconomic disparities in the receipt of SGLT2i therapy versus other glucose-lowering medications.18”
From Disparities in SGLT2 Inhibitor or Glucagon-Like Peptide 1 Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United States (2023) · cites this paper as [18]
In the citing paper
“Two recent studies analyzed the use of SGLT2i based on sociodemographic and clinical factors. Both studies, however, focused on commercially insured and Medicare Advantage patients without CKD.”
From Disparities in SGLT2 Inhibitor or Glucagon-Like Peptide 1 Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United States (2023) · cites this paper as [18]
In the citing paper
“The study reported that higher median household income (≥$100,000 vs <$50, 000) was associated with a higher rate of adoption of SGLT2i.”
From Disparities in SGLT2 Inhibitor or Glucagon-Like Peptide 1 Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United States (2023) · cites this paper as [18]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · cited 2×
“In general, comorbid conditions have been handled analytically by: (1) stratifying patients into groups-those with a comorbidity and those without; (2) using separate binary indicators for discrete conditions; or (3) summarizing comorbidity information into an index or score that provides a single parameter for measur…”
MethodResultAdapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717
Practical considerations on the use of the charlson comorbidity index with administrative data bases
D'Hoore, W., Bouckaert, A., & Tilquin, C. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00271-5 · Cited by 893
The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus
Kaplan, M. H., & Feinstein, A. R. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90017-4 · Cited by 670
Risk Adjustment in Outcome Assessment: the Charlson Comorbidity Index
Sicotte, C., Tilquin, C., & D’Hoore, W. (1993) · Methods of Information in Medicine · doi:10.1055/s-0038-1634956 · Cited by 545
Greenfield, S., Apolone, G., McNeil, B. J., & Cleary, P. D. (1993) · Medical Care · doi:10.1097/00005650-199302000-00005 · Cited by 493
Iezzoni, L. I. (1992) · JAMA · doi:10.1001/jama.267.16.2197 · Cited by 447
Surgical Rates and Operative Mortality for Open and Laparoscopic Cholecystectomy in Maryland
Steiner, C. A., Bass, E. B., Talamini, M. A., Pitt, H. A., & Steinberg, E. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402103300607 · Cited by 366
Self-citationClinical Versus Administrative Data Bases for CABG Surgery: Does it Matter
Hannan, E. L., Kilburn, H., Lindsey, M. L., & Lewis, R. (1992) · Medical Care · doi:10.1097/00005650-199210000-00002 · Cited by 237
Research works printed but not linked: 5
- Fowles, 1996, JAMA, 276, 1316, 10.1001/jama.1996.03540160038030 · doi:10.1001/jama.1996.03540160038030 · Paper page
- Landon, 1996, Inquiry, 33, 155
- Iezzoni, 1994, Health Serv Res, 29, 435
- Krakauer, 1992, Health Serv Res, 27, 317
- McGovern, 1992, JAMA, 268, 753, 10.1001/jama.1992.03490060085029 · doi:10.1001/jama.1992.03490060085029 · Paper page
Cited by
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
“Dr. Quan is supported by a Population Health Investigator Award from the Alberta Heritage Foundation for Medical Research, Edmonton, Alberta, Canada, and by a New Investigator Award from the Canadian Institutes of Health Research.”
BackgroundMethodInfluentialQuan, H., Li, B., Couris, C. M., Fushimi, K., Graham, P., Hider, P., Januel, J.-M., & Sundararajan, V. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq433 · Cited by 5,843
“(24) analyzed a large hospital discharge database to assess the association of numerous comorbidities (including Charlson comorbidities) with in-hospital mortality and formed an index.”
Prevalence, Expenditures, and Complications of Multiple Chronic Conditions in the Elderly
Wolff, J. L., Starfield, B., & Anderson, G. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.20.2269 · Cited by 2,233
“Our measure of preventable complications is based on diagnoses originally defined by DesHarnais16 and refined by Elixhauser et al.17 Preventable complications incurred during hospitalization were identified using 42 ICD-9-CM diagnoses listed in any position on an inpatient hospitalization administrative claim.”
Methodvan Walraven, C., Austin, P. C., Jennings, A., Quan, H., & Forster, A. J. (2009) · Medical Care · doi:10.1097/mlr.0b013e31819432e5 · Cited by 2,200
Development of a comorbidity index using physician claims data
Klabunde, C. N., Potosky, A. L., Legler, J. M., & Warren, J. L. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00256-0 · Cited by 1,845
Metadata
- Authors
- Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M.
- Corresponding author
- Elixhauser, Anne
- Venue
- Medical Care
- Published
- 1998-01
- Volume
- 36
- Issue
- 1
- Pages
- 8-27
- ISSN
- 0025-7079 (ISSN-L)
- OpenAlex
- W2057780602
- Cited by
- 9,921
- References
- 33
- Citations by year
- 2026: 460 · 2025: 552 · 2024: 627 · 2023: 746 · 2022: 810 · 2021: 811 · 2020: 717 · 2019: 670 · 2018: 596 · 2017: 545 · 2016: 541 · 2015: 518 · 2014: 458 · 2013: 371 · 2012: 308
- FWCI
- 8.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medical Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Health Professions › Health Information Management › Medical Coding and Health Information
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- administrative data, hospitalization outcomes, length of hospital stay, hospital charges, in-hospital mortality, mental illness, alcohol and drug abuse, obesity, coagulopathy, weight loss, fluid and electrolyte disorders, hospitalization
- MeSH terms
- Adult, Algorithms, California, Data Interpretation, Statistical, Diagnosis-Related Groups, Health Services Research, Humans, Length of Stay, Middle Aged, Outcome and Process Assessment, Health Care, Reproducibility of Results, Comorbidity, Hospital Mortality, Hospital Charges
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comorbidity measures for use with administrative data. https://app.cochat.ai/papers/10.1097/00005650-199801000-00004
- The paper
- Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998). Comorbidity measures for use with administrative data. Medical Care. https://doi.org/10.1097/00005650-199801000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.